Biofrontera (BFRIW) Competitors $0.11 -0.06 (-36.97%) As of 11:38 AM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsSEC FilingsTrendsBuy This Stock BFRIW vs. ATNFW, LBPSW, AEHAW, AIMDW, ALVOW, ACABW, BTMDW, BCTXW, CELUW, and CINGWShould you be buying Biofrontera stock or one of its competitors? The main competitors of Biofrontera include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), Atlantic Coastal Acquisition Corp. II (ACABW), biote (BTMDW), BriaCell Therapeutics (BCTXW), Celularity (CELUW), and Cingulate (CINGW). These companies are all part of the "pharmaceutical products" industry. Biofrontera vs. 180 Life Sciences 4D pharma Aesther Healthcare Acquisition Ainos Alvotech Atlantic Coastal Acquisition Corp. II biote BriaCell Therapeutics Celularity Cingulate 180 Life Sciences (NASDAQ:ATNFW) and Biofrontera (NASDAQ:BFRIW) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, risk, community ranking, earnings, profitability, dividends, valuation, institutional ownership and media sentiment. Does the MarketBeat Community favor ATNFW or BFRIW? 180 Life Sciences and Biofrontera both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperform180 Life SciencesN/AN/ABiofronteraN/AN/A Does the media prefer ATNFW or BFRIW? In the previous week, 180 Life Sciences' average media sentiment score of 0.00 equaled Biofrontera'saverage media sentiment score. Company Overall Sentiment 180 Life Sciences Neutral Biofrontera Neutral Is ATNFW or BFRIW more profitable? Company Net Margins Return on Equity Return on Assets 180 Life SciencesN/A N/A N/A Biofrontera N/A N/A N/A Which has better valuation and earnings, ATNFW or BFRIW? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio180 Life SciencesN/AN/AN/AN/AN/ABiofrontera$37.32MN/AN/AN/AN/A SummaryBiofrontera beats 180 Life Sciences on 1 of the 1 factors compared between the two stocks. Get Biofrontera News Delivered to You Automatically Sign up to receive the latest news and ratings for BFRIW and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BFRIW vs. The Competition Export to ExcelMetricBiofronteraDrug Manufacturers IndustryMedical SectorNASDAQ ExchangeMarket CapN/A$2.17B$5.35B$8.38BDividend YieldN/A2.92%5.22%4.10%P/E RatioN/A3.9826.8419.71Price / SalesN/A529.96391.39116.98Price / CashN/A10.2538.2534.62Price / BookN/A6.926.794.50Net IncomeN/A$20.70B$3.23B$248.18M7 Day Performance5.75%0.55%4.07%1.14%1 Month PerformanceN/A5.30%12.52%15.20%1 Year PerformanceN/A91.10%16.83%6.56% Biofrontera Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BFRIWBiofronteraN/A$0.11-37.0%N/A+56.5%$0.00$37.32M0.0070Positive NewsGap UpATNFW180 Life SciencesN/A$0.01+14.8%N/A+21.5%$0.00N/A0.007Positive NewsGap DownHigh Trading VolumeLBPSW4D pharmaN/AN/AN/AN/A$0.00$522,000.000.00N/AAEHAWAesther Healthcare AcquisitionN/A$0.01flatN/A-89.5%$0.00N/A0.002AIMDWAinosN/A$0.10-24.2%N/A+71.4%$0.00$20,729.000.0040ALVOWAlvotechN/A$1.79flatN/A-41.9%$0.00$489.68M0.004Positive NewsGap UpACABWAtlantic Coastal Acquisition Corp. IIN/A$0.02flatN/A-77.9%$0.00N/A0.0015BTMDWbioteN/A$0.02+43.9%N/AN/A$0.00$199.38M0.00N/AHigh Trading VolumeBCTXWBriaCell TherapeuticsN/A$0.06-14.2%N/A-74.1%$0.00N/A0.008CELUWCelularityN/A$0.04-14.2%N/A+108.3%$0.00$48.20M0.00220Positive NewsGap UpCINGWCingulateN/A$0.04-0.3%N/A+28.0%$0.00N/A0.0020Positive NewsGap Down Related Companies and Tools Related Companies 180 Life Sciences Competitors 4D pharma Competitors Aesther Healthcare Acquisition Competitors Ainos Competitors Alvotech Competitors Atlantic Coastal Acquisition Corp. II Competitors biote Competitors BriaCell Therapeutics Competitors Celularity Competitors Cingulate Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BFRIW) was last updated on 5/21/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Biofrontera Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Biofrontera With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.